Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Bovine Kisspeptin ELISA Kit (AC3037)
Cat.#: ASET-1626
Specifications
Description Bovine Kisspeptin ELISA Kit allows for the in vitro quantitative determination of bovine Kisspeptin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Bovine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2107 Rat Slit2 ELISA Kit (AC3518) Quantitative inquiry ASET-1332 Human Somatostatin Receptor 2 ELISA Kit (AC2743) Quantitative inquiry ASET-1659 Mouse VPAC2 ELISA Kit (AC3070) Quantitative inquiry ASET-1722 Human NDP ELISA Kit (AC3133) Quantitative inquiry ASET-1453 Human Neurofibromin ELISA Kit (AC2864) Quantitative inquiry ASET-1186 Human TRPC5 ELISA Kit (AC2597) Quantitative inquiry ASET-1954 Rat Progesterone Receptor ELISA Kit (AC3365) Quantitative inquiry ASET-2336 Rat Synaptophysin ELISA Kit (AC3747) Quantitative inquiry ASET-1532 Rat CaMKII beta ELISA Kit (AC2943) Quantitative inquiry ASET-1711 Human APLP1 ELISA Kit (AC3122) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket